Association of childhood asthma with Gasdermin B genes

OBJECTIVE: Genome-length association studies have shown that Gasdermin B (GSDMB) and Orosomucoid-like 3 (ORMDL3) genes located on the long arm of chromosome 17 are associated with asthma. In this study, it was aimed to determine the possible relationship between asthma control test (ACT), exercise p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:İstanbul Kuzey Klinikleri 2023-12, Vol.10 (6), p.769
Hauptverfasser: Almacioglu, Mehmet, Keskin, Ozlem, Ozkars, Mehmet Yasar, Balci, Sibel Oguzkan, Kucukosmanoglu, Ercan, Pehlivan, Sacide, Keskin, Mehmet
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:OBJECTIVE: Genome-length association studies have shown that Gasdermin B (GSDMB) and Orosomucoid-like 3 (ORMDL3) genes located on the long arm of chromosome 17 are associated with asthma. In this study, it was aimed to determine the possible relationship between asthma control test (ACT), exercise provocation test (ECT), and fractional nitric oxide (FENO) levels and GSDMB and ORMDL3 gene expressions. METHODS: 59 asthmatic and 38 non-asthmatic children were included in the study. We divided the patient group into two subgroups as mild persistent asthma (29 patients) and moderate persistent asthma (30 patients). ORMDL3, GSDMB gene expression levels, ECT, total IgE levels, and eosinophil counts were measured in all cases. In addition, ACT and FeNO levels were measured in children with asthma. Afterward, the relationship of ORMDL3 and GSDMB gene expression coefficient changes with ECT, ACT, and FeNO was examined. RESULTS: When patients with ACT [less than or equal to] 15 were compared with patients with ACT [greater than or equal to] 20, ORMDL3 and GSDMB gene expressions were increased 6.74 and 11.74 times, respectively. Comparing patients with ACT [greater than or equal to] 20 and ACT [less than or equal to] 15 in terms of coefficient changes ([DELTA]Cq), higher change values were observed for [DELTA]Cq ORMDL3 in patients with ACT [less than or equal to] 15 (p=0.015). Similarly, when patients with FENO [less than or equal to] 25 ppb were compared with patients with FENO >25 ppb, ORMDL3 and GSDMB gene expressions were increased by 2.93 and 3.56 times, respectively. When the coefficient changes were compared, no significant difference was found between FENO [less than or equal to] 25 and FENO >25 patients. There was a slight negative correlation between [DELTA]Cq values and ACT score (p=0.003, r=-0.418 for ORMDL3, and p=0.016, r=-0.345 for GSDMB). In addition, we observed a statistically significant positive correlation between ORMDL3 and GSDMB gene expressions (r=0.80, p
ISSN:2148-4902
DOI:10.14744/nci.2023.22120